Karyopharm Therapeutics Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Karyopharm Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was 58.6 %, a 75.5% decline year-over-year.
  • Karyopharm Therapeutics Inc. annual Return On Equity for 2023 was 162 %, a 12.6% decline from 2022.
  • Karyopharm Therapeutics Inc. annual Return On Equity for 2022 was 186 %, a 22.8% increase from 2021.
  • Karyopharm Therapeutics Inc. annual Return On Equity for 2021 was 151 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 162 -23.4 -12.6% Jan 1, 2023 Dec 31, 2023
2022 186 +34.4 +22.8% Jan 1, 2022 Dec 31, 2022
2021 151 +334 Jan 1, 2021 Dec 31, 2021
2020 -182 +72.3 +28.4% Jan 1, 2020 Dec 31, 2020
2019 -255 -147 -137% Jan 1, 2019 Dec 31, 2019
2018 -108 -18 -20.1% Jan 1, 2018 Dec 31, 2018
2017 -89.6 -23.2 -34.9% Jan 1, 2017 Dec 31, 2017
2016 -66.4 -16.2 -32.4% Jan 1, 2016 Dec 31, 2016
2015 -50.2 -7.52 -17.6% Jan 1, 2015 Dec 31, 2015
2014 -42.7 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.